From: Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer
LVEF
Mean ± SD (%)
LVEF1 T
64.69 (SD 4.48)
LVEF2 T
60.58 (SD 6.58)
LVEF1 TE
61.75 (SD 3.85)
LVEF2 TE
59.54 (SD 4.12)